SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-126674
Filing Date
2016-06-08
Accepted
2016-06-08 20:34:17
Documents
1
Period of Report
2016-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7512
  Complete submission text file 0001209191-16-126674.txt   8927
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Issuer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O DIMENSION THERAPEUTICS, INC. 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Clark K. Reed (Reporting) CIK: 0001653061 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37601 | Film No.: 161704771